Literature DB >> 23395655

Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine.

Shouyi Xuan1, Yanbin Wu, Xiaofang Chen, Jun Liu, Aixia Yan.   

Abstract

In this study, four computational quantitative structure-activity relationship models were built to predict the biological activity of HIV-1 integrase strand transfer (ST) inhibitors. 551 Inhibitors whose bioactivities were detected by radiolabeling method were collected. The molecules were represented with 20 selected MOE descriptors. All inhibitors were divided into a training set and a test set with two methods: (1) by a Kohonen's self-organizing map (SOM); (2) by a random selection. For every training set and test set, a multilinear regression (MLR) analysis and a support vector machine (SVM) were used to establish models, respectively. For the test set divided by SOM, the correlation coefficients (rs) were over 0.91, and for the test set split randomly, the rs were over 0.86.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395655     DOI: 10.1016/j.bmcl.2013.01.081

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Classification of Plasmodium falciparum glucose-6-phosphate dehydrogenase inhibitors by support vector machine.

Authors:  Xiaoli Hou; Aixia Yan
Journal:  Mol Divers       Date:  2013-05-09       Impact factor: 2.943

2.  QSAR Study on Anti-HIV-1 Activity of 4-Oxo-1,4-dihydroquinoline and 4-Oxo-4H-pyrido[1,2-a]pyrimidine Derivatives Using SW-MLR, Artificial Neural Network and Filtering Methods.

Authors:  Zahra Hajimahdi; Amin Ranjbar; Amir Abolfazl Suratgar; Afshin Zarghi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

3.  Artificial Intelligence-Based Application to Explore Inhibitors of Neurodegenerative Diseases.

Authors:  Leping Deng; Weihe Zhong; Lu Zhao; Xuedong He; Zongkai Lian; Shancheng Jiang; Calvin Yu-Chian Chen
Journal:  Front Neurorobot       Date:  2020-12-22       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.